Citigroup’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $710K | Sell |
|
|||||
|
2025
Q1 | $914K | Buy |
|
|||||
|
2024
Q4 | $614K | Buy |
|
|||||
|
2024
Q3 | $420K | Sell |
|
|||||
|
2024
Q2 | $3.53M | Buy |
|
|||||
|
2024
Q1 | $585K | Buy |
|
|||||
|
2023
Q4 | $53.2K | Sell |
|
|||||
|
2023
Q3 | $282K | Buy |
|
|||||
|
2023
Q2 | $179K | Buy |
|
|||||
|
2023
Q1 | $5.39K | Sell |
|
|||||
|
2022
Q4 | $6.46K | Sell |
|
|||||
|
2022
Q3 | $7K | Sell |
|
|||||
|
2022
Q2 | $26K | Buy |
|
|||||
|
2022
Q1 | $20K | Sell |
|
|||||
|
2021
Q4 | $96K | Buy |
|
|||||
|
2021
Q3 | $63K | Buy |
|
|||||
|
2021
Q2 | $29K | Sell |
|
|||||
|
2021
Q1 | $101K | Sell |
|
|||||
|
2020
Q4 | $196K | Buy |
|
|||||
|
2020
Q3 | $27K | Buy |
|
|||||
|
2020
Q2 | $5K | Sell |
|
|||||
|
2020
Q1 | $3K | Sell |
|
|||||
|
2019
Q4 | $16K | Sell |
|
|||||
|
2019
Q3 | $12K | Sell |
|
|||||
|
2019
Q2 | $27K | Buy |
|
|||||
|
2019
Q1 | $35K | Sell |
|
|||||
|
2018
Q4 | $41K | Sell |
|
|||||
|
2018
Q3 | $228K | Buy |
|
|||||
|
2018
Q2 | $68K | Buy |
|
|||||
|
2018
Q1 | $18K | Buy |
|
|||||
|
2017
Q4 | $15K | Sell |
|
|||||
|
2017
Q3 | $81K | Buy |
|
|||||
|
2017
Q2 | $40K | Sell |
|
|||||
|
2017
Q1 | $44K | Sell |
|
|||||
|
2016
Q4 | $160K | Buy |
|
|||||
|
2016
Q3 | $129K | Buy |
|
|||||
|
2016
Q2 | $128K | Buy |
|
|||||
|
2016
Q1 | $136K | Buy |
|
|||||
|
2015
Q4 | $58K | Sell |
|
|||||
|
2015
Q3 | $103K | Sell |
|
|||||
|
2015
Q2 | $501K | Sell |
|
|||||
|
2015
Q1 | $1.54M | Sell |
|
|||||
|
2014
Q4 | $1.37M | Buy |
|
|||||
|
2014
Q3 | $31K | Sell |
|
|||||
|
2014
Q2 | $35K | Buy |
|
|||||
|
2014
Q1 | $44K | Buy |
|
|||||
|
2013
Q4 | $6K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $0 | Buy |
|